References

10.1182/bloodadvances.2026019984 · 2026 · Admitted local publication

Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)

10.1182/blood.2019000937 · 2020 · External reference

Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia

10.1080/1042819031000139611 · 2004 · External reference

Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations

10.1111/nyas.12346 · 2014 · External reference

Hematologic malignancies in pediatric patients with RUNX1-familial platelet disorder with associated myeloid malignancy

10.1182/bloodadvances.2025017808 · 2026 · External reference

Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies

10.1038/s41375-021-01200-w · 2021 · External reference

Validation and clinical application of transactivation assays for RUNX1 variant classification

10.1182/bloodadvances.2021006161 · 2022 · External reference

Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit

10.1128/mcb.18.5.2444 · 1998 · External reference

Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors

10.1073/pnas.95.20.11590 · 1998 · External reference

Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder

10.3109/10428194.2010.503821 · 2010 · External reference